Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1978 March; 37(3): 377–385.
PMCID: PMC2009531

Responses of proliferating and non-proliferating Chinese hamster cells to cytotoxic agents.


The effects of various cytotoxic chemicals, as measured by viable cell counts, colony-forming ability and proliferative capacity, have been studied using Chinese hamster cells in exponential and plateau (stationary) phases of growth. The proliferating cells were altogether more sensitive to the action of the drugs than non-proliferating cells. However, imuran (azathioprine) a purine antimetabolite, was more effective against the plateau-phase cells. The observed response of cells to imuran could be detected at a wide range of concentrations (1-100 microgram/ml). These findings are discussed in view of the possible ability of imuran to interfere with active metabolic processes in non-proliferating cells.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Barranco SC, Novak JK, Humphrey RM. Response of mammalian cells following treatment with bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea during plateau phase. Cancer Res. 1973 Apr;33(4):691–694. [PubMed]
  • Barranco SC, Novak JK, Humphrey RM. Studies on recovery from chemically induced damage in mammalian cells. Cancer Res. 1975 May;35(5):1194–1204. [PubMed]
  • Bhuyan BK, Fraser TJ, Day KJ. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells. Cancer Res. 1977 Apr;37(4):1057–1063. [PubMed]
  • Bruce WR, Meeker BE, Valeriote FA. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst. 1966 Aug;37(2):233–245. [PubMed]
  • Cooper HL. Studies on RNA metabolism during lymphocyte activation. Transplant Rev. 1972;11:3–38. [PubMed]
  • Furth JJ, Cohen SS. Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine. Cancer Res. 1968 Oct;28(10):2061–2067. [PubMed]
  • Gonzalez EM, Krejczy K, Malt RA. Modification of nucleic acid synthesis in regenerating liver by azathioprine. Surgery. 1970 Jul;68(1):254–259. [PubMed]
  • Hahn GM. Metabolic aspects of the role of hyperthermia im mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Res. 1974 Nov;34(11):3117–3123. [PubMed]
  • Hahn GM, Gordon LF, Kurkjian SD. Responses of cycling and noncycling cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and to bleomycin. Cancer Res. 1974 Sep;34(9):2373–2377. [PubMed]
  • Hahn GM, Stewart JR, Yang SJ, Parker V. Chinese hamster cell monolayer cultures. I. Changes in cell dynamics and modifications of the cell cycle with the period of growth. Exp Cell Res. 1968 Feb;49(2):285–292. [PubMed]
  • Holley RW. Control of growth of mammalian cells in cell culture. Nature. 1975 Dec 11;258(5535):487–490. [PubMed]
  • Kohn A. Differential effects of isoleucine deprivation on cell motility, membrane transport and DNA synthesis in NIL 8 hamster cells. Exp Cell Res. 1975 Aug;94(1):15–22. [PubMed]
  • Malamud D, Gonzalez EM, Chiu H, Malt RA. Inhibition of cell proliferation by azathioprine. Cancer Res. 1972 Jun;32(6):1226–1229. [PubMed]
  • Marsh JC. The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. Cancer Res. 1976 Jun;36(6):1853–1882. [PubMed]
  • Mauro F, Falpo B, Briganti G, Elli R, Zupi G. Effects of antineoplastic drugs on plateau-phase cultures of mammalian cells. I. Description of the plateau-phase system. J Natl Cancer Inst. 1974 Mar;52(3):705–713. [PubMed]
  • Mauro F, Falpo B, Briganti G, Elli R, Zupi G. Effects of antineoplastic drugs on plateau-phase cultures of mammalian cells. II. Bleomycin and hydroxyurea. J Natl Cancer Inst. 1974 Mar;52(3):715–722. [PubMed]
  • Müller WE, Obermeier J, Maidhof A, Zahn RK. Distamycin: an inhibitor of DNA-dependent nucleic acid synthesis. Chem Biol Interact. 1974 Mar;8(3):183–192. [PubMed]
  • Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1286–1290. [PubMed]
  • PUCK TT, CIECIURA SJ, FISHER HW. Clonal growth in vitro of human cells with fibroblastic morphology; comparison of growth and genetic characteristics of single epithelioid and fibroblast-like cells from a variety of human organs. J Exp Med. 1957 Jul 1;106(1):145–158. [PMC free article] [PubMed]
  • Sutherland RM. Selective chemotherapy of noncycling cells in an in vitro tumor model. Cancer Res. 1974 Dec;34(12):3501–3503. [PubMed]
  • Tobey RA. Arrest of Chinese hamster cells in G 2 following treatment with the anti-tumor drug bleomycin. J Cell Physiol. 1972 Apr;79(2):259–266. [PubMed]
  • Tobey RA, Crissman HA. Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression. Cancer Res. 1975 Feb;35(2):460–470. [PubMed]
  • Tobey RA, Oka MS, Crissman HA. Differential effects of two chemotherapeutic agents, streptozotocin and chlorozotocin, on the mammalian cell cycle. Eur J Cancer. 1975 Jun;11(6):433–441. [PubMed]
  • Twentyman PR, Bleehen NM. The sensitivity of cells in exponential and stationary phases of growth to bleomycin and to 1,3-bis(2-chloroethyl)-1-nitrosourea. Br J Cancer. 1973 Dec;28(6):500–507. [PMC free article] [PubMed]
  • Valeriote F, van Putten L. Proliferation-dependent cytotoxicity of anticancer agents: a review. Cancer Res. 1975 Oct;35(10):2619–2630. [PubMed]
  • Van Putten LM, Lelieveld P, Kram-Idsenga LK. Cell-cycle specificity and therapeutic effectiveness of cytostatic agents. Cancer Chemother Rep. 1972 Dec;56(6):691–700. [PubMed]
  • Watanabe M, Takabe Y, Katsumata T, Terasima T. Effects of bleomycin on progression through the cell cycle of mouse L-cells. Cancer Res. 1974 Apr;34(4):878–881. [PubMed]
  • Yataganas X, Strife A, Perez A, Clarkson BD. Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1974 Oct;34(10):2795–2806. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK